glucose, (beta-d)-isomer has been researched along with Inflammatory Response Syndrome, Systemic in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 11 (73.33) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Aratani, Y; Endo, D; Sugimoto, Y | 1 |
Bayarri-Olmos, R; Garred, P; Kirketerp-Moller, N; Pérez-Alós, L; Skjodt, K; Skjoedt, MO | 1 |
Fang, L; Liu, K; Peng, J; Sun, P; Xu, L; Xu, M; Yin, L; Zhao, X | 1 |
Cao, L; Dong, H; Hou, L; Jia, W; Jing, W; Wang, C; Wei, H; Yang, S; Zhang, Y | 1 |
Goss, KL; Hilkin, BM; Hook, JS; Moreland, JG; Newell, EA; Whitmore, LC | 1 |
Bai, XD; Hu, S; Li, JY; Li, YM; Wang, HB; Zhao, ZK; Zheng, JG | 1 |
García-Cenador, MB; García-Criado, FJ; García-García, MI; García-Moro, M; García-Sánchez, E; García-Sánchez, JE; Lorenzo-Gómez, MF; Lozano-Sánchez, F; Sánchez-Conde, MP | 1 |
Bramanti, P; Cuzzocrea, S; Di Paola, R; Galuppo, M; Mazzon, E; Paterniti, I | 1 |
Ashton, SH; Borg, KT; Cook, JA; Fan, H; Halushka, PV; Wong, D | 1 |
Bramanti, P; Cuzzocrea, S; Di Paola, R; Impellizzeri, D; Mazzon, E; Paterniti, I | 1 |
Lu, QY; Meng, L; Quan, S; Wang, JB; Wang, L; Weng, JK; Yu, B; Zhou, YY | 1 |
Bai, X; Dong, H; Du, K; Han, H; Hou, L; Hu, S; Huang, Y; Li, S; Lu, Y; Mu, J; Pei, Y; Wang, W; Xiong, L; Zhang, Z; Zhao, Y | 1 |
Hu, S; Jiang, XG; Jin, H; Li, JY; Lu, JY; Lü, Y; Sheng, ZY; Zhang, R | 1 |
Barros, MB; García-Criado, FJ; Gomez-Alonso, A; Lozano, FS | 1 |
Ghanekar, A; Lindsay, TF; Memari, N; Romaschin, A; Walker, P | 1 |
15 other study(ies) available for glucose, (beta-d)-isomer and Inflammatory Response Syndrome, Systemic
Article | Year |
---|---|
Mice Deficient in NOX2 Display Severe Thymic Atrophy, Lymphopenia, and Reduced Lymphopoiesis in a Zymosan-Induced Model of Systemic Inflammation.
Topics: Animals; Atrophy; Disease Models, Animal; Dose-Response Relationship, Drug; Granulomatous Disease, Chronic; Lymphopenia; Lymphopoiesis; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; Systemic Inflammatory Response Syndrome; Thymus Gland; Zymosan | 2021 |
Development of a Quantitative Assay for the Characterization of Human Collectin-11 (CL-11, CL-K1).
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; CHO Cells; Chromatography, Gel; Collectins; Complement C4; Cricetulus; Enzyme-Linked Immunosorbent Assay; Freezing; Humans; Lectins; Mannose-Binding Protein-Associated Serine Proteases; Protein Binding; Statistics, Nonparametric; Systemic Inflammatory Response Syndrome; Zymosan | 2018 |
Protective effects of dioscin against systemic inflammatory response syndromevia adjusting TLR2/MyD88/NF‑κb signal pathway.
Topics: Animals; Anti-Inflammatory Agents; Dioscorea; Diosgenin; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Systemic Inflammatory Response Syndrome; THP-1 Cells; Toll-Like Receptor 2; Zymosan | 2018 |
Regulatory T cells are protective in systemic inflammation response syndrome induced by zymosan in mice.
Topics: Animals; Cytokines; Disease Models, Animal; Lung; Lymphocyte Depletion; Male; Mice; Systemic Inflammatory Response Syndrome; T-Lymphocytes, Regulatory; Zymosan | 2013 |
NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome.
Topics: Animals; Bone Marrow Cells; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Lung; Lung Injury; Macrophage Activation; Macrophages; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; NADPH Oxidase 2; NADPH Oxidases; Neutrophil Infiltration; Systemic Inflammatory Response Syndrome; Zymosan | 2014 |
Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction.
Topics: Amine Oxidase (Copper-Containing); Animals; Apoptosis; Dimethyl Sulfoxide; Enteritis; Free Radical Scavengers; Interleukin-10; Intestinal Mucosa; Male; Malondialdehyde; Multiple Organ Failure; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Superoxide Dismutase; Systemic Inflammatory Response Syndrome; Tight Junctions; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein; Zymosan | 2015 |
Comparative study of bacterial translocation control with nitric oxide donors and COX2 inhibitor.
Topics: Animals; Bacterial Translocation; Celecoxib; Cyclooxygenase 2 Inhibitors; Male; Molsidomine; Nitric Oxide Donors; Rats; Rats, Wistar; Systemic Inflammatory Response Syndrome; Zymosan | 2016 |
PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
Topics: Acute Disease; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Adhesion Molecules; Cytokines; Fas Ligand Protein; Flavonoids; I-kappa B Proteins; Inflammation Mediators; Male; Mice; Mitogen-Activated Protein Kinases; Multiple Organ Failure; Neutrophil Infiltration; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Peritonitis; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Systemic Inflammatory Response Syndrome; Time Factors; Transcription Factor RelA; Tyrosine; Zymosan | 2010 |
Beneficial effect of a CXCR4 agonist in murine models of systemic inflammation.
Topics: Animals; Chemokine CXCL12; Disease Models, Animal; Endotoxemia; Interleukin-10; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; Multiple Organ Failure; Receptors, CXCR4; Sepsis; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha; Zymosan | 2012 |
Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice.
Topics: Acetophenones; Animals; Apoptosis; Cytokines; Enzyme Inhibitors; Male; Mice; Multiple Organ Failure; NADPH Oxidases; Nitrates; Nitrites; Onium Compounds; Reactive Oxygen Species; Shock; Systemic Inflammatory Response Syndrome; Zymosan | 2011 |
[Preparation of rat model of systemic inflammatory response syndrome induced by zymosan].
Topics: Animals; Disease Models, Animal; Female; Interleukin-10; Interleukin-6; Male; Paraffin; Rats; Rats, Sprague-Dawley; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha; Viscera; Zymosan | 2011 |
Activation of cholinergic anti-inflammatory pathway contributes to the protective effects of 100% oxygen inhalation on zymosan-induced generalized inflammation in mice.
Topics: Aconitine; Animals; Cytokines; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Lung; Male; Mecamylamine; Mice; Mice, Inbred ICR; Myocardium; Nicotinic Antagonists; Oxygen; Receptors, Nicotinic; Respiratory Insufficiency; Systemic Inflammatory Response Syndrome; Vagotomy; Zymosan | 2012 |
[A small dose of intraperitoneal injection of zymosan induces systemic inflammatory response and multiple organ dysfunction following gut ischemia-reperfusion injury].
Topics: Animals; Disease Models, Animal; Male; Multiple Organ Failure; Rats; Rats, Wistar; Reperfusion Injury; Systemic Inflammatory Response Syndrome; Zymosan | 2003 |
Exogenous nitric oxide can control SIRS and downregulate NFkappaB.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; beta-Glucans; Biocompatible Materials; Biomarkers; Blood Vessel Prosthesis Implantation; Down-Regulation; Intercellular Adhesion Molecule-1; Male; Models, Animal; NF-kappa B; Nitric Oxide; Polyethylene Terephthalates; Rats; Rats, Wistar; Single-Blind Method; Systemic Inflammatory Response Syndrome; Zymosan | 2005 |
Rupture of an abdominal aortic aneurysm causes priming of phagocytic oxidative burst.
Topics: Acridines; Aged; Anaphylatoxins; Aortic Aneurysm, Abdominal; Aortic Rupture; Cell Count; Complement C3a; Complement Pathway, Classical; Elective Surgical Procedures; Humans; Indicators and Reagents; Luminescent Measurements; Luminol; Macrophage-1 Antigen; Phagocytes; Protein Kinase C; Respiratory Burst; Systemic Inflammatory Response Syndrome; Tetradecanoylphorbol Acetate; Zymosan | 1997 |